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Antibacterial activityAbstract A simple and efﬁcient one-pot synthesis of heteroaryl substititued dihydropyr-
ano(c)chromenes and pyrano[2,3-d]pyrimidines has been developed via initial Knoevenagel, subse-
quent Micheal and ﬁnal heterocyclization reactions of heteroaryl aldehyde, malononitrile and
barbituric acid/ dimedone. 1,4-Diazabicyclo [2.2.2] octane (DABCO) has been used as a catalyst.
Short reaction time, environment friendly procedure and excellent yields are the main advantages
of this procedure. All synthesized compounds have shown good antimicrobial activity against dif-
ferent microbial stains.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University.
Open access under CC BY-NC-ND license.1. Introduction
Polyfuctionalized pyran derivatives are common structural
subunits in variety of important natural products including
alkaloids, pheromones, carbohydrates, antibiotics, insecticides
and herbicides (Bonsignore et al., 1993; Ramazani and Reza
Fattahi, 2002; Kim and Lee, 2002). Multi-component reactions
(MCRs) have attracted considerable interest because of theirexceptional synthetic and practical efﬁciency (Hamad et al.,
2010; Seiﬁ and Sheibani, 2008; Suresh Babu and
Raghunathan, 2006). MCRs involve three or more starting
materials reacting in a single ﬂask to form a new product,
where basically all the atoms contribute to the newly formed
product. Dihydropyrano(c)chromenes and pyrano[2,3-
d]pyrimidines are some examples of multi-component synthe-
sis. Dihydropyrano(c)chromene and pyrano[2,3-d]pyrimidine
structures are of considerable interest as they possess a wide
range of biological properties such as spasmolytic, diuretic,
anticoagulant, antitumor, antiallergic, anticoagulant, anti-can-
cer and anti-anaphylactic activity and potassium channel acti-
vators (Bonsignore et al., 1993; Evans et al., 1990; Arnoldi
et al., 1990). In addition, they can be used as cognitive enhanc-
ers, for the treatment of neurodegenerative diseases (Berger,
1970). A number of 2-amino-2H pyrans are useful as photoac-
tive substances also (Armesto et al., 1989). Some of the
Table 2 Effect of different concentration of catalyst for the
synthesis of 6a in EtOH–H2O at room temp.
Entry Catalyst Conc. Time (min) Yield** (%)
1 DABCO 1 mol% 60 72
2 DABCO 5 mol% 45* 95
3 DABCO 10 mol% 45 92
4 DABCO 20 mol% 45 90
5 DABCO 30 mol% 30 89
6 No catalyst – 180* 56 (18)#
* No change observed in yield even after prolonged stirring up to
4 h.
** Isolated yield.
# Knoevenagel product.
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ano(c)chromenes and pyrano[2,3-d]pyrimidines include the
use of ammonium acetate as a catalyst and the solvents like
DMF or acetic acid; (Kamaljit et al., 1996; Balalaie et al.,
2008; Wang et al., 2003; Singh et al., 1996) but these solvents
make the workup tedious and lead to poor yields of the prod-
ucts (Akbar et al., 2010; Bararjanian et al., 2009). These meth-
ods often suffer from certain drawbacks such as long time
procedures, hazardous by-products, microwave irradiations,
use of stoichiometric or even excess amount of base and use
of metal triﬂates (Raghuvanshi and Singh, 2010).
Diazabicyclo [2.2.2] octane (DABCO) or triethyldiamine
(TEDA) is a weak base and used in many reactions like
acceleration of benzoylation reaction, Baylis–Hillman reac-
tion, self and cross-condensation of a-acetylenic ketones,
coupling of a-keto-esters with acrylonitrile etc. as a base cat-
alyst. DABCO is a non-toxic, inexpensive, and commercially
available catalyst that can be used in laboratory without
special precautions (Da-Zhen et al., 2010; Luque and
Duncan, 2009; Luca et al., 2006). But, it has not been used
much as a catalyst in pyran synthesis, only a few reports are
therein the literature (Balalaie et al., 2008; Beheshtia et al.,
2010; Balalaie et al., 2008). This prompted us to develop a
new synthetic way for heteroaryl substituted dihydropyrano
(c)chromenes and pyrano[2,3-d]pyrimidines by using DAB-
CO as a catalyst. It is documented that malononitrile under-
goes standard Knoevenagel condensation with aromatic
aldehyde to yield the corresponding arylidene derivatives
(Chang-Hee et al., 2004; Rahmati and Vakili, 2010; Ali
et al., 2007; Yadav et al., 2004; Bhuyan and Deb, 2005)
which are versatile substrates for different kinds of reactions,
as well as useful intermediates for cycloaddition reactions
and for the synthesis of heterocyclic compounds with poten-
tial pharmacological activity. Therefore, in the present
paper; we wish to report one-pot synthesis of heteroaryl
substituted pyran derivatives 6/7 via a three component
reaction of aldehyde, malononitrile and dimedone/barbituric
acid using DABCO as catalyst. We found, DABCO as an
efﬁcient organic base catalyst for one-pot multi-component
synthesis with high yields. The synthesis not only preserves
the simplicity but also gives the corresponding compounds
of biological interest in high yields in lesser time.Table 1 DABCO promoted synthesis of heteroaryl substituted pyr
Entry Aldehyde 1 DABCO AMC\ 2 Ti
1 1a 5 mol% Dimedone 45
2 1b 5 mol% Dimedone 40
3 1c 5 mol% Dimedone 50
4 1d 5 mol% Dimedone 40
5 1e 5 mol% Dimedone 45
6 1f 5 mol% Dimedone 40
7 1a 5 mol% Barbituric Acid 30
8 1b 5 mol% Barbituric Acid 40
9 1c 5 mol% Barbituric Acid 50
10 1d 5 mol% Barbituric Acid 40
11 1e 5 mol% Barbituric Acid 45
12 1f 5 mol% Barbituric Acid 45
a Bhosale et al. (2003).
b Gao et al. (2002).1.1. Physical properties of DABCO or TEDA
(a) Appearance: Solid.
(b) Colour: White.
(c) Odour: No speciﬁc.
(d) Melting range: 156–159 C.
(e) Boiling range: 174 C.
(f) Vapour pressure: 3.9 hPa at 50 C.
(g) Relative density: 1.02 g/mL at 25 C.
(h) Water solubility: Soluble.
(i) Mol. Formula: C6H12N2
2. Results and discussion
The polyfunctionalized dihydropyrano(c)chromene and pyr-
ano[2,3-d]pyrimidine derivatives have been synthesized in pres-
ence of DABCO in aqueous ethanol at room temperature.
5 mol% of catalyst concentration and equimolar ratio of each
reactant give the best results (Table 2). In the absence of the
catalyst, the reaction was rather sluggish and resulted in poor
yield (56%) along with furylidenemalononitrile (21%) even
after a long reaction time (4 h) under the same conditions, thus
conﬁrming the role of DABCO as a catalyst for the reaction.
DABCO being basic in character, will facilitate the removalano(c)chromene and pyrano[2,3-d]pyrimidine.
me (min) Product Yield\\ (%) mp (C)
6a 95 218 [217–219]a
6b 94 205–207 [204–205]
6c 84 178–180
6d 95 208–210 [209–211]b
6e 95 214–215
6f 97 217–219
7a 92 280–282
7b 94 284–286
7c 86 191–193
7d 95 274–275
7e 96 289–291
7f 97 >320
Table 3 Comparative synthesis of 6a using the reported methods versus present method.
Entry Catalyst Conditions Time (min) Yield (%)
1 LiBr H2O/Reﬂux 15 95
c
2 TBAF H2O/Reﬂux 30 97
d
3 N-methylamidazole H2O, RT 90 91
e
4 N-methylamidazole Grinding 3 87e
5 ANP H2O, RT 5 98
f
6 DABCO EtOH–H2O 45 95
c Sun et al. (2010).
d Gao et al. (2002).
e Wang et al. (2003).
f Song et al. (2010).
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Scheme 2 A plausible mechanism for the preparation of
dihydropyrano(c)chromene.
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increasing the reaction rate. It can be easily removed by aque-
ous washing of the product as it is soluble in water, hence no
need of neutralization after completion of the reaction. The
effect of various catalysts such as LiBr, tetrabutylammonium
ﬂuoride (TBAF), (NH4)2HPO4, N-Methylamidazole and cata-
lyst-free condition for this transformation were screened. Of
these catalysts DABCO was found to be better in terms of
yields and time. To further expand the scope of the present
method the replacement of dimedone with barbituric acid
was examined. To our delight, under the same conditions,
the reactions proceeded steady to provide the targeted pyr-
ano[2,3-d]pyrimidines in good yields. In comparison with other
catalysts such as tetrabutylammonium ﬂuoride (TBAF),
(NH4)2HPO4, threo-(1S,2S)-2-amino-1-(4-nitrophenyl)-1,3-
propane -diol (ANP), N-Methylamidazole and LiBr which
were recently reported in the formation of the pyr-
ano(c)chromenes, DABCO (used here) shows equal or more
efﬁcient catalytic activity in terms of reaction times and yields
of the products (Table 3). This one-pot three component
method offers an alternative route for the synthesis of pyr-
ano-chromene and pyrano-pyrimidine in reasonable yields. It
is expected that synthesis of 6/7 follows initial arylidinemalo-
nontrile formation followed by Michael addition of 4/5 to 3
and on heterocyclization gives intermediate 8. Intermediate 8
on tautomerization (proton transfer) give 6/7 (Scheme 2).
Structures of the products 6 and 7 have been deduced from
their elemental analysis, spectral data (IR, 1H, 13C and Mass)
and melting points. These products are valuable building
blocks in organic synthesis as they possess various functional
groups and have shown good biological activities against some
gram positive and gram negative bacteria.
The antimicrobial screening has shown that the products 7c
and 7d displayed broad-spectrum activity against Klebsiella
pneumoniae, 6a and 7a against Pseudomonas aeruginosa and
6d and 7d against both Escherichia coli and Salmonella typhi.
It is clear that compounds 6a, 6d, 7c and 7d possess high activ-
ity, while rest of the compounds possess moderate activity.Scheme 1 DABCO catalyzed synthesis of dihydrop3. Experimental section
Melting points were determined by open capillary method and
were uncorrected. 1H NMR spectra were obtained on a BRU-
KER instrument (300 MHz). IR spectra were recorded on a
Perkin–Elmer 298 spectrophotometer. Reactions have been
monitored by thin layer chromatography on 0.2 mm silica
gel F-252 (Merck) plates. All chemicals were obtained from
Aldrich Chemical Co. and S.D. Finechem Co. and used with-
out further puriﬁcation. Antimicrobial activity was tested by
the disk diffusion method (Grivsky et al., 1980; Bauer et al.,
1966).yrano(c)chromene and pyrano[2,3-d]pyrimidine.
Table 4 Antimicrobial activity of some compounds.
Entry Product Escherichia Coli Salmonella typhi Klebsiella pneumoniae Pseudomonas aeruginosa
1 6a ++ +++ ++ +++
2 6c ++ + ++ +
3 6d +++ +++ + +
4 7a ++ ++ + +++
5 7c ++ ++ +++ +
6 7d +++ +++ +++ +
Zone area += 6–10 mm, ++= 11–15 mm, +++= 16–20 mm.
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pyrano(c)chromene or pyrano[2,3-d]pyrimidine: 5-membered
heteroaryl aldehyde (2 mmol), malononitrile (2 mmol), 5,50-
dimethyl-cyclohexane-1,3-dione/barbituric acid (2 mmol) and
5 mol% DABCO were added to a R.B. ﬂask containing
15 mL (EtOH:H2O) solvent mixture (Scheme 1). The reaction
mixture was stirred for appropriate time at room temp
(Table 1). The completion of the reaction was monitored on
TLC. The solid obtained was washed with distilled water
(3 · 10 mL) for removal of the catalyst. The product was
extracted with dichloromethane and ﬁltered; the solvent was
evaporated under reduced pressure. The pure product (6/7)
was obtained by recrystallization from ethanol: water (4:1).
3.1. Antibacterial evaluation
Antibacterial activity of the prepared compounds 6 and 7a, c, d
were tested by the disk diffusion method. Whattman No. 1 ﬁl-
ter paper disks were sterilized by autoclaving for 1 h at 140 C.
The sterile disks were impregnated with the test compounds
(250 mg/mL). Agar plates were uniformly surface inoculated
with fresh broth culture of Staphylococcus aureus, P. aerugin-
osa, Klebshiella pneumoniae and E. coli. The impregnated disks
were placed on the medium suitably spaced apart and the
plates were incubated at 30 C for 1 h to permit good diffusion
and were then transferred to an incubator at 37± 2 C for
24 h. The zones of inhibition were measured on mm scale.
The results of antimicrobial activity tests are listed in Table 4.
3.2. Spectroscopic data
3.2.1. 2-Amino-3-cyano-4-(furan-2-yl)-7,7-dimethyl-5-oxo-4H-
5,6,7,8-tetrahydrobenzo-[b]pyran
6a white solid, m.p. 216–218 C; IR (KBr) mmax: 3355, 3327
(NH2), 2974 (CAH), 2202 (CN), 1680 (C‚O), 1652
(C‚C)cm1; 1H NMR (DMSO-d6): d 0.99 (s, 3H, CH3),
1.05 (s, 3H, CH3), 2.17 (m, 2H, CH2), 2.48 (m, 2H, CH2),
4.33 (s, 1H, CH), 6.32 (dd, J= 3.9, 1.8 Hz, 1H, ArAH),
6.05 (d, J= 3.9 Hz, 1H, ArAH), 7.07 (br, s, 2H, NH2), 7.48
(d, J= 3.9 Hz, 1H, ArAH) ppm; EI-MS (m/z): 284 (M+),
265, 256, 241, 227, 217, 210, 199, 184, 153, 145; C16H16N2O3
(284.32): Calcd. C, 67.59; H, 5.67; N, 9.85. Found: C, 67.88;
H, 5.56; N, 9.63.
3.2.2. 2-Amino-7,7-dimethyl-4-(5-methyl-furan-2-yl)-5-oxo-
5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
6b yellow solid, m.p. 205–207 C; IR (KBr) mmax: 3396, 3210
(NH2), 2966 (CAH), 2196 (CN), 1680 (C‚O), 1660(C‚C) cm1; 1H NMR (DMSO-d6): d 2.17 (s, 3H, CH3),
6.32 (d, J= 3.9, 1.8 Hz, ArAH), 6.05 (d, J= 3.9Hz, ArAH),
7.08 (br, s, 2H, NH2), 4.33 (s, 1H), 2.50 (s, 2H, CH2), 2.30 (s,
2H, CH2), 1.04 (s, 3H, CH3), 0.99 (s, 3H, CH3) ppm; EI-MS
(m/z): 298(M+), 282, 281, 272, 255, 241, 227, 217, 145, 133;
C17H18N2O3 (298.34): Calcd. C, 68.44; H, 6.08; N, 9.39.
Found: C, 68.40; H, 6.10; N, 9.41.
3.2.3. 2-Amino-7,7-dimethyl-5-oxo-4-(1H-pyrrol-2-yl)-5,6,7,8-
tetrahydro-4H-chromene-3-carbonitrile
6c white solid, m.p. 178–180 C; IR (KBr) mmax: 3355, 3208
(NH2), 2941 (CAH), 2212 (CN), 1675 (C‚O), 1658
(C‚C) cm1; 1H NMR (DMSO-d6): d 0.99 (s, 3H, CH3), 1.08
(s, 3H, CH3), 2.22 (s, 2H, CH2), 2.42 (s, 2H, CH2), 4.31 (s,
1H), 5.21 (s, 1H, NH), 6.05 (dd, J= 2.5, 3.4 Hz, 1H, ArAH),
5.91 (d, J= 3.4 Hz, ArAH), 6.32 (d, J= 3.4 Hz, ArAH), 7.07
(br, s, 2H, NH2); EI-MS (m/z): 283(M+), 265, 255, 241, 217,
210, 199; C16H17N3O2 (283.33): Calcd. C, 67.83; H, 6.05; N,
14.83. Found: C, 67.88; H, 5.99; N, 14.84.
3.2.4. 2-Amino-7,7-dimethyl-4-(thiophen-2-yl)-5-oxo-5,6,7,8-
tetrahydro-4H-chromene-3-carbonitrile
6d yellow solid, m.p. 208–210 C; IR (KBr) mmax: 3402, 3212
(NH2), 2977 (CAH), 2206 (CN), 1678 (C‚O), 1662
(C‚C) cm1; 1H NMR (DMSO-d6): d 6.32–6.33 (dd, 1H,
J= 3.4 Hz, 1H, ArAH), 6.15 (d, J= 3.4 Hz, 1H, ArAH),
6.05 (d, J= 3.4 Hz, 1H, ArAH), 7.08 (br, s, 2H, NH2), 4.33
(s, 1H, CH), 2.50 (s, 2H, CH2), 2.30 (s, 2H, CH2), 1.04 (s,
3H, CH3), 0.99 (s, 3H, CH3). EI-MS (m/z): 300 (M+), 227,
217, 202, 156, 149; C16H16N2O2S (300.09): Calcd. C, 63.98;
H, 5.37; N, 9.33 Found: C, 63.92; H, 5.34; N, 9.42.
3.2.5. 2-Amino-7,7-dimethyl-4-(3-methyl-thiophen-2-yl)-5-oxo-
5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
6e light yellow, m.p. 214–215 C; IR (KBr) mmax: 3396, 3209
(NH2), 2966 (CAH), 2196 (CN), 1680 (C‚O), 1660 (C‚C)
cm1; 1H NMR (DMSO-d6),: d 2.29 (s, 3H,CH3), 6.33 (d,
J= 3.4 Hz, 1H, ArAH), 6.05 (d, J= 3.4 Hz, 1H, ArAH),
7.08 (s, 2H, NH2), 4.33 (s, 1H, CH), 2.50 (s, 2H, CH2), 2.35
(s, 2H, CH2), 1.04 (s, 3H, CH3), 0.99 (s, 3H, CH3); EI-MS
(m/z): 314 (M+), 298, 227, 217, 191, 175, 149; C17H18N2O2S
(314.11): Calcd. C, 64.94; H, 5.77; N, 8.91. Found: C, 64.98;
H, 5.73; N, 8.89.
3.2.6. 2-Amino-7,7-dimethyl-4-(5-methyl-thiophen-2-yl)-5-oxo-
5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
6f yellow solid, m.p. 217–219 C IR (KBr) mmax: 3386, 3219
(NH2), 2976 (CAH), 2189 (CN), 1679 (C‚O), 1661 (C‚C)
DABCO promoted one-pot synthesis of dihydropyrano(c)chromene and pyrano [2,3-d]pyrimidine derivatives and their biological activities 539cm1; 1H NMR (DMSO-d6) d: 2.19 (s, 3H, CH3), 6.35 (d,
J= 3.0 Hz, ArAH), 6.05 (d, J= 3.2 Hz, ArAH), 7.08 (br s,
2H, NH2), 4.33 (s, 1H, CH), 2.50 (s, 2H, CH2), 2.30 (s, 2H,
CH2), 1.04 (s, 3H, CH3), 0.99 (s, 3H, CH3); EI-MS (m/z):
314(M+), 298, 227, 217, 175, 149; C17H18N2O2S (314.11):
Calcd. C, 64.94; H, 5.77; N, 8.91. Found: C, 64.92; H, 5.75;
N, 8.86.
3.2.7. 7-Amino-5-furan-2-yl-2,4-dioxo-1,3,4,5-tetrahydro-2H-
pyrano[2,3-d]pyrimidine-6-carbonitrile
7a dark yellow solid, m.p. 280–282 C; IR (KBr) mmax: 3391,
3302 (NH2), 3188 (NH), 3072 (CAH), 2197 (CN), 1718
(C‚O), 1665 (C‚C) cm1; 1H NMR (DMSO-d6): d 4.26 (s,
CH), 7.20 (br, s, 2H, NH2), 7.22 (1H, d, HAAr), 6.59 (dd,
J= 3.0 Hz, 1H, ArAH), 6.51 (d, J= 3.0 Hz, 1H, ArAH),
11.12 (1H, br s, NH), 12.14 (br s, 1H, NH); EI-MS (m/z):
272 (M+), 246, 216, 205, 176, 149, 110; C12H8N4O4 (272.22):
Calcd. C, 52.95; H, 2.96; N, 20.58. Found: C, 52.94; H, 2.93;
N, 20.47.
3.2.8. 7-Amino-5-(5-methyl-furan-2-yl)-2,4-dioxo-1,3,4,5-
tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile
7b dark yellow solid, m.p. 284–286 C; IR (KBr) mmax: 3402,
3299 (NH2), 3178 (NH), 2989 (CAH), 2202 (CN), 1715
(C‚O), 1460 (C‚C) cm1; 1H NMR (DMSO-d6) d: 4.12
(1H, s, CH), 7.16 (2H, br, s, NH2), 2.15 (3H, s, CH3), 6.59
(1H, m, ArAH), 6.51 (1H, d, ArAH), 11.12 (1H, br s, NH),
12.14 (1H, br, s, NH); EI-MS (m/z): 286 (M+), 271, 270,
260, 244, 205, 149, 100; C13H10N4O4 (286.24): Calcd. C,
54.55; H, 3.52; N,19.57 Found: C, 54.46; H, 3.56; N, 19.59.
3.2.9. 7-Amino-2,4-dioxo-5-(1H-pyrrol-2-yl)-1,3,4,5-
tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile
7c pale-yellow solid, m.p. 191–193 C; IR (KBr) mmax: 3402,
3299 (NH2), 3168 (NH), 2989 (CAH), 2202 (CN), 1708
(C‚O), 1460 (C‚C) cm1; 1H NMR (DMSO-d6) d: 4.19
(1H, s, CH), 7.10 (2H, br, s, NH2), 6.97 (1H, d, ArAH),
6.59 (1H, m, ArAH), 6.51 (1H, d, ArAH), 11.12 (1H, br, s,
NH), 12.14 (1H, br, s, NH); EI-MS (m/z): 271 (M+), 246,
217, 205, 176, 148; C12H9N5O3 (271.23): Calcd. C, 53.14; H,
3.34; N, 25.82. Found: C, 53.07; H, 3.28; N, 25.89.
3.2.10. 7-Amino-5-(thiophen-2-yl)-2,4-dioxo-1,3,4,5-
tetrahydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile
7d dark yellow solid, m.p. 274–275 C; IR (KBr) mmax: 3390,
3306 (NH2), 3188 (NH), 3072 (CAH), 2197 (CN), 1708
(C‚O), 1459 (C‚C) cm1; 1H NMR (DMSO-d6) d: 4.21
(1H, s), 7.38 (2H, br, s, NH2), 7.02 (1H, d, ArAH), 6.57
(1H, m, ArAH), 6.49 (1H, d, ArAH), 11.42 (1H, br, s, NH),
12.09 (1H, br, s, NH); EI-MS (m/z): 288 (M+), 263, 232,
221, 201, 176, 149, 110; C12H8N4O3S (288.28): Calcd. C,
50.00; H, 2.80; N, 19.43. Found: C, 49.89; H, 2.84; N,19.46.
3.2.11. 7-Amino-5-(3-methyl-thiophen-2-yl)-2,4-dioxo-1,3,4,5-
tetra hydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile
7e yellow solid, m.p. 289–291 C; IR (KBr) mmax: 3399,
3281 (NH2), 3174 (NH), 2981 (CAH), 2200 (CN), 1707
(C‚O), 1463 (C‚C) cm1; 1H NMR (DMSO-d6) d: 3.99
(1H, s, CH), 7.26 (2H, br, s, NH2), 2.20 (3H, s, CH3),
6.62 (1H, m, ArAH), 6.48 (1H, d, ArAH), 11.02 (1H, br,s, NH), 12.04 (1H, br, s, NH); EI-MS (m/z): 302 (M+),
278, 248, 217, 221, 176, 149, 110; C13H10N4O3S (302.5):
Calcd. C, 51.65; H, 3.33; N, 18.53 Found: C, 51.62; H,
3.36; N, 18.57.
3.2.12. 7-Amino-5-(5-methyl-thiophen-2-yl)-2,4-dioxo-1,3,4,5-
tetra hydro-2H-pyrano[2,3-d]pyrimidine-6-carbonitrile
7f yellow solid, m.p. > 320 C; IR (KBr) mmax: 3402, 3299
(NH2), 3178 (NH), 2989 (CAH), 2202 (CN), 1715 (C‚O),
1460 (C‚C) cm1; 1H NMR (DMSO-d6) d: 4.02 (1H, s,
CH), 7.16 (2H, br, s, NH2), 2.26 (3H, s, CH3), 6.59 (1H, m,
ArAH), 6.51 (1H, d, ArAH), 11.12 (1H, br, s, NH), 12.14
(1H, br, s, NH); EI-MS (m/z): 302 (M+), 278, 248, 217, 221,
176, 149, 110; C13H10N4O3S (302.05): Calcd. C, 51.65; H,
3.33; N,18.53 Found: C, 51.62; H, 3.38; N, 18.51.
4. Conclusions
We have demonstrated a rapid and an efﬁcient synthetic route
for DABCO catalysed one-pot three component synthesis of
dihydropyrano(c)chromenes and pyrano[2,3-d]pyrimidines in
aqueous ethanol solvent mixture at room temperature and
the The current technology has the advantages of operational
simplicity, mild reaction conditions and good to high yield of
the products.
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